Barbara Gayle Duncan, a director of Theravance, recently acquired 19,857 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on April 20, 2017. Duncan now owns 52,318 shares of the company. Duncan operates out of Brisbane, CA. Some additional info was provided as follows:
The Reporting Person was granted restricted stock units ("RSUs"). 100% of the RSUs will vest at the sooner of the next annual shareholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Theravance makes a similar move, sign up!
Other recent filings from the company include the following:
Theravance's Chief Accounting Officer just declared owning 24,104 shares of Theravance - Aug. 13, 2018
Departure of Directors or Certain - Aug. 8, 2018